2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with elacridar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alink, GM; Freidig, AP; Groten, JP; Rietjens, IM; Schutte, ME; van de Sandt, JJ | 1 |
1 other study(ies) available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and elacridar
Article | Year |
---|---|
An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
Topics: Acridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Caco-2 Cells; Carcinogens; Cell Membrane Permeability; Diffusion; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Humans; Imidazoles; Intestinal Absorption; Intestinal Mucosa; Kinetics; Membrane Transport Proteins; Models, Biological; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Reproducibility of Results; Tetrahydroisoquinolines | 2006 |